Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease

Annals of Allergy, Asthma and Immunology

Volumn 105, Issue 2, 2010, Pages 130-135

  Lee, Rachel U ^a   White, Andrew A ^a   Ding, Ding ^b   Dursun, Adile Berna ^c   Woessner, Katharine M ^a   Simon, Ronald A ^a   Stevenson, Donald D ^a  

^a SCRIPPS CLINIC   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTACID AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; KETOROLAC; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING BETA 2 ADRENERGIC RECEPTOR AGONIST; MONTELUKAST; NASACORT AQ; PROTON PUMP INHIBITOR; RANITIDINE; STEROID; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; ZAFIRLUKAST; ZILEUTON; KETOROLAC TROMETAMOL;

ADULT; AGED; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DESENSITIZATION; DIAGNOSTIC VALUE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; HUMAN; LARYNX SPASM; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; NOSE; PEAK NASAL INSPIRATORY FLOW; PRIORITY JOURNAL; REPEATED DRUG DOSE; SKIN DISEASE; SPIROMETRY; SYMPTOM; TREATMENT DURATION; ADOLESCENT; ANALOGS AND DERIVATIVES; ASTHMA, ASPIRIN-INDUCED; COMPARATIVE STUDY; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ASPIRIN; ASTHMA, ASPIRIN-INDUCED; CLINICAL PROTOCOLS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; KETOROLAC TROMETHAMINE; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS;

EID: 77955229557     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.05.020     Document Type: Article

References (15)

1. M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson Treatment with aspirin desensitization in patients with aspirin exacerbated respiratory disease J Allergy Clin Immunol 111 2003 180 186
2. M. Kowalski, I. Grzelewska-Rzymowska, M. Szmidt, and J. Rozniecki Clinical efficacy of aspirin in "desensitized" aspirin-sensitive asthmatics Eur J Respir Dis 69 1986 219 225
3. D.D. Stevenson, and R.A. Simon Selection of patients for aspirin desensitization J Allergy Clin Immunol 116 2006 80 84
4. J. Casadevall, P.J. Ventura, J. Mullol, and C. Picado Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry Thorax 55 2000 921 924
5. G. Patriarca, P. Bellioni, and E. Nucera Intranasal treatment with lysine acetylsalcylate in patients with nasal polyposis Ann Allergy Asthma Immunol 67 1991 588 593
6. A.A. White, T.A. Bigby, and D.D. Stevenson Intranasal ketorolac challenge for the diagnosis of aspirin exacerbated respiratory disease Ann Allergy Asthma Immunol 97 2006 190 195
7. A.P. Hope, K.A. Woessner, R.A. Simon, and D.D. Stevenson Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease J Allergy Clin Immunol 123 2009 406 410
8. D.D. Stevenson Aspirin desensitization in patients with AERD Clin Rev Allergy Immunol 24 2003 159 167
9. D.D. Stevenson Aspirin sensitivity and desensitization for asthma and sinusitis Curr Allergy Asthma Rep 9 2009 155 163
10. M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson The effect of leukotriene modifier drugs on aspirin-induced asthma and rhinitis reactions Clin Exp Allergy 32 2002 1491 1496
11. A.A. White, D.D. Stevenson, and R.A. Simon The blocking effect of essential controller medications during aspirin challenges in patients with aspirin exacerbated respiratory disease Ann Allergy Asthma Immunol 95 2005 330 335
12. A.A. White, E. Ludington, P. Mehra, D.D. Stevenson, and R.A. Simon Effect of leukotriene modifier drugs on the safety of OACs Ann Allergy Asthma Immunol 97 2006 688 693
13. A.N. Williams, R.A. Simon, K.M. Woessner, and D.D. Stevenson The relationship between historical aspirin-induced asthma and the severity of asthma induced during oral aspirin challenges J Allergy Clin Immunol 120 2007 273 277
14. J.C. Delaney The diagnosis of aspirin idiosyncrasy by analgesic challenge Clin Allergy 6 1976 177 181
15. A.B. Dursun, K.A. Woessner, R.A. Simon, D. Karasoy, and D.D. Stevenson Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps and chronic sinusitis Ann Allergy Asthma Immunol 100 2008 420 425